Regeneron, Intellia target neurological diseases in expanded gene editing deal
BioPharma Dive,
Regeneron Pharmaceuticals and Intellia Therapeutics are again expanding a longstanding research partnership, this time with a…
Regeneron Pharmaceuticals and Intellia Therapeutics are again expanding a longstanding research partnership, this time with a…
Share on PinterestMicroglia are thought to be key drivers of many neurological conditions, including Alzheimer’s disease.
Existen más virus que estrellas en el universo. Para hacernos una idea de la cantidad tan ingente que hay, cualquiera que lea…